Action is essential component of PBM reform in the Medicaid program and vital for patients and the pharmacies serving them.
Organizations commend House Committee on Oversight and Accountability for hearing on PBM tactics.
NACDS President and CEO Steven C. Anderson released the following statement today in anticipation of a legislative markup on May 24 by the U.S. House of Representatives Committee on Energy and Commerce:
Implementation of NYRx New York Medicaid pharmacy benefit celebrated.
NACDS celebrates the enactment of a Florida bill holding PBMs accountable, marking a major victory for patients.
NACDS’ Principles of PBM Reform include “stopping the undercutting of reform laws” – as part of a comprehensive effort to end “pharmaceutical benefit manipulation” that harms patients, employers, taxpayers, communities, and pharmacies.
As Senate Finance Committee releases legislative framework, NACDS emphasizes its Principles of PBM Reform to ensure comprehensive and lasting solutions for patients, pharmacies, employers, taxpayers, communities, and the nation.
NACDS is lauding legislation introduced by U.S. Senators Peter Welch (D-VT) and Roger Marshall (R-KS) to crack down on tactics by which “pharmaceutical benefit manipulator” middlemen maximize profits at the expense of patients, pharmacies, and others.
NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit.
Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue.
